Aignostics earns ISO 27001 certification for information security
August 09, 2022
Aignostics announced today that its Information Security Management System has been certified according to DIN EN ISO/IEC 27001:2017 by the TÜV SÜD Management Service GmbH. The certification covers Aignostics’ development of AI powered diagnostics solutions, the provision of research services, and the operation of Aignostics’ web-based platform “Portal”.
ISO/IEC 27001 is the leading international standard for information security management systems (“ISMS”) and underlines Aignostics’ commitment to information security and data protection.
The certification will further facilitate the sharing of research and clinical data with Aignostics by its pharma and biotech clients, and allow for a more seamless interaction with Aignostics client platform “Portal”. The certification also underpins Aignostics’ efforts to deploy its AI models for clinical trials.
“Regulatory excellence is a key focus of Aignostics as an organization, and we think information security and data protection are of utmost importance in our space, given that patients and partners trust us to handle their information with the highest possible degree of care. We are very proud of our ISMS team and the whole organization who worked hard to achieve this certification.”, said Viktor Matyas, CEO of Aignostics.
Aignostics is a spin-off from Charité – Universitätsmedizin Berlin, and a global leader in the development of AI-powered precision diagnostics for pathology. Started in 2018, Aignostics’ has 50+ employees in Germany and the US, and is primarily active in pre-clinical, translational, and clinical research with globally leading pharma and biotech clients.
Viktor Matyas, CEO
MC Services AG
Kaja Skorka, Dr. Regina Lutz
Phone: +49 89-210 2280